Search
Scinai Immunotherapeutics Ltd
SCNIAdd to Watchlist
0.270USD
-0.001-0.29%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
956.00KMarket Cap
LossP/E TTM
More Details of Scinai Immunotherapeutics Ltd Company
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Scinai Immunotherapeutics Ltd Info
Ticker SymbolSCNI
Company nameScinai Immunotherapeutics Ltd
IPO dateJun 07, 2007
CEOReichman (Amir)
Number of employees31
Security typeDepository Receipt
Fiscal year-endJun 07
AddressJerusalem Biopark, 2Nd Floor
CityJERUSALEM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code00000
Phone97289302529
Websitehttps://www.scinai.com/
Ticker SymbolSCNI
IPO dateJun 07, 2007
CEOReichman (Amir)
Company Executives of Scinai Immunotherapeutics Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Amir Reichman
Mr. Amir Reichman
Chief Executive Officer, Director
Chief Executive Officer, Director
400.02M
+100.00%
Mr. Mark S. Germain
Mr. Mark S. Germain
Chairman of the Board
Chairman of the Board
120.00M
--
Mr. Elad Mark
Mr. Elad Mark
Chief Operating Officer
Chief Operating Officer
4.87K
+73.89%
Dr. Tamar Ben-Yedidia
Dr. Tamar Ben-Yedidia
Chief Scientific Officer
Chief Scientific Officer
1.35K
--
Mr. Uri Ben-Or, CPA
Mr. Uri Ben-Or, CPA
Chief Financial Officer
Chief Financial Officer
1.18K
+76.63%
Prof. Avner Rotman
Prof. Avner Rotman
Director
Director
50.00
-36.00%
Dr. Yael Margolin
Dr. Yael Margolin
External Director
External Director
50.00
--
Mr. Adi Raviv
Mr. Adi Raviv
External Director
External Director
50.00
--
Mr. Samuel J. Moed
Mr. Samuel J. Moed
Director
Director
--
--
Dr. Morris C. Laster, M.D.
Dr. Morris C. Laster, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Amir Reichman
Mr. Amir Reichman
Chief Executive Officer, Director
Chief Executive Officer, Director
400.02M
+100.00%
Mr. Mark S. Germain
Mr. Mark S. Germain
Chairman of the Board
Chairman of the Board
120.00M
--
Mr. Elad Mark
Mr. Elad Mark
Chief Operating Officer
Chief Operating Officer
4.87K
+73.89%
Dr. Tamar Ben-Yedidia
Dr. Tamar Ben-Yedidia
Chief Scientific Officer
Chief Scientific Officer
1.35K
--
Mr. Uri Ben-Or, CPA
Mr. Uri Ben-Or, CPA
Chief Financial Officer
Chief Financial Officer
1.18K
+76.63%
Prof. Avner Rotman
Prof. Avner Rotman
Director
Director
50.00
-36.00%
FAQs
Who are the top five shareholders of Scinai Immunotherapeutics Ltd?
The top five shareholders of Scinai Immunotherapeutics Ltd are: Mr. Amir Reichman
How many institutions hold shares of Scinai Immunotherapeutics Ltd (SCNI)?
As of 2026Q1, 23 institutions hold shares of Scinai Immunotherapeutics Ltd, with a combined market value of approximately 179.71K, accounting for 5.08% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 33890.00.